Learn more at LeadIQ.com

Insights

Gathering insights about Antengene…

Similar companies to Antengene

Antengene Tech Stack

Antengene uses 8 technology products and services including WordPress Super Cache, WordPress, MySQL, and more. Explore Antengene's tech stack below.

WordPress Super Cache
Caching
WordPress
Content Management System
MySQL
Database
Vue.js
Javascript Frameworks
Slick
Javascript Libraries
jQuery
Javascript Libraries
Swiper
Javascript Libraries
Animate.css
UI Frameworks

Media & News

Antengene Corp. is developing XPOVIO in combination therapies for the treatment of various diseases.
Based on its unique mechanism of action, Antengene is developing XPOVIO(R) in combination therapies for the treatment of various diseases, including diffuse large B-cell lymphoma (DLBCL), T-cell non-Hodgkin's lymphoma (T-NHL), and myelofibrosis (MF).
Dec 13, 2023 | en.prnasia.com
Antengene Corp. launches anti-cd24 monoclonal antibody ATG-031.
Antengene announces Phase I study of anti-cd24 monoclonal antibody ATG-031.
Sep 20, 2023 | www.prnewswire.com
Antengene Corp. receives financing of $27.5M in upfront payments.
Antengene will receive approximately $27.5 million in upfront payments, with $13 million upon the initial signing.
Aug 13, 2023 | www.pharmexec.com
Antengene Corp. partners with Jiangsu Hansoh Pharmaceutical Group.
Antengene enters into commercialization partnership with Hansoh Pharma for first/only-in-class XPO1 inhibitor XPOVIO (selinexor) in the mainland of China.
Aug 09, 2023 | www.cmocro.com
Antengene Corp. launches patient dosed in the nivolumab combination portion of the clinical study evaluating the ERK1/2 inhibitor ATG-017 in Patients.
Antengene announces first patient dosed in the nivolumab combination portion of the clinical study evaluating the ERK1/2 inhibitor ATG-017 in Patients with advanced solid tumors in the United States.
Jul 17, 2023 | www.prnewswire.com
Antengene Corp. launches XPOVIO regulatory approval.
Antengene announces XPOVIO® regulatory approval in Hong Kong for the treatment of Relapsed and/or refractory Multiple Myeloma.
Jul 16, 2023 | www.prnewswire.com
Antengene Corp. partnered with Celularity Inc. on Jul 19th '22.
After a careful and comprehensive evaluation, Antengene is very pleased to initiate its first research collaboration in the important field of cellular medicine with Celularity.”
Jul 18, 2022 | pharmafocusasia.com

Antengene's Email Address Formats

Antengene uses at least 1 format(s):

Antengene Email Formats	Example	Percentage
First.Last@antengene.com	John.Doe@antengene.com	49%
Last@antengene.com	Doe@antengene.com	1%
First-Last@antengene.com	John-Doe@antengene.com	1%
First.Last@antengene.com	John.Doe@antengene.com	49%

Frequently Asked Questions

Where is Antengene's headquarters located?

Antengene's main headquarters is located at Shanghai, Changning District 200000 CN. The company has employees across 4 continents, including AsiaNorth AmericaOceania.

What is Antengene's official website and social media links?

Antengene's official website is antengene.com and has social profiles on LinkedIn.

What is Antengene's NAICS code?

Antengene's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Antengene have currently?

As of May 2024, Antengene has approximately 201 employees across 4 continents, including AsiaNorth AmericaOceania. Key team members include Chief Of Staff, Assistant Coo: A. G.Vice President Medical Affairs, Apac And Early Clinical Development: D. H.Head Of Medical Affairs, Apac: T. E.. Explore Antengene's employee directory with LeadIQ.

What industry does Antengene belong to?

Antengene operates in the Pharmaceutical Manufacturing industry.

What technology does Antengene use?

Antengene's tech stack includes WordPress Super CacheWordPressMySQLVue.jsSlickjQuerySwiperAnimate.css.

What is Antengene's email format?

Antengene's email format typically follows the pattern of . Find more Antengene email formats with LeadIQ.

How much funding has Antengene raised to date?

As of May 2024, Antengene has raised $97M in funding. The last funding round occurred on Jul 20, 2020 for $97M.

When was Antengene founded?

Antengene was founded in 2017.

Antengene

Antengene

Pharmaceutical ManufacturingChangning District, China201-500 Employees

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of Treating Patients Beyond Borders. 

Since 2017, Antengene has built a pipeline of 9 oncology programs at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region. We have successfully obtained marketing authorizations for selinexor, Antengene’s lead asset, in multiple Asia Pacific counties and regions including mainland China, Taiwan,China, South Korea, Singapore, and Australia.

Company Overview

Headquarters: Shanghai, Changning District 200000 CN
Website: antengene.com
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Founded: 2017
Employees: 201-500

Media & News

Funding & Financials

$97M
Antengene has raised a total of $97M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2020 in the amount of $97M.

Funding & Financials

$97M
Antengene has raised a total of $97M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2020 in the amount of $97M.

Company Leadership

A. G.
Chief Of Staff, Assistant Coo
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. H.
Vice President Medical Affairs, Apac And Early Clinical Development
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. E.
Head Of Medical Affairs, Apac
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. M.
Founder, Chairman & Chief Executive Officer
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. T.
Key Accounts Manager Lead Sg/Hk And Partner Markets Commercialization
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

P. Q.
Vice President, Human Resources And Corporate Affairs
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. E.
Head Of Medical Affairs, Apac
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. K.
Cvp & Head Of Asia Pacific Markets
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Z. Y.
Corporate Vice President, Biometrics And Regulatory Enabling Functions
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. R.
Senior Director - Commercialisation
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Antengene and Millions of Other Companies
Sign up for full access to Antengene information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.